Drupal.behaviors.print = function(context) {window.print();window.close();}>
Cancer Analysis Firm PGDx Licenses Genome Mapping Technology from Johns Hopkins
March 07, 2013
Cancer Analysis Firm PGDx Licenses Genome Mapping Technology from Johns Hopkins
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Turning Pap Test into Sequencing-Based Gynecologic Cancer Assay will Take Further Validation
February 6, 2013 / Clinical Sequencing News
Startup Aims to Translate Hopkins Team's Cancer Genomics Expertise into Patient Care
May 16, 2012 / Clinical Sequencing News
Asuragen In-licenses BRAF Mutation from Johns Hopkins
June 2, 2010 / GenomeWeb Daily News
Empire Genomics Licenses Biomarker from Cornell to Develop Prostate Cancer Dx
May 22, 2013 / GenomeWeb Daily News
Personal Genome Diagnostics, Blueprint Medicines to ID Novel Drug Targets in Cancer
May 21, 2013 / GenomeWeb Daily News